| Serum 25(OH)D3 Levels | P-value | ||
---|---|---|---|---|
 | <20 ng/mL | 20 ng/mL-30 ng/mL | ≥30 ng/mL | |
Hypercholesterolemia (%) | 53.3 | 25.4 | 21.4 | Â |
Unadjusted | 1 | 0.896 | 1.14 | 0.644 |
(Reference) | (0.646,1.242) | (0.800,1.625) | Â | |
Model 1a | 1 | 0.922 | 1.204 | 0.447 |
(Reference) | (0.663,1.282) | (0.840,1.724) | Â | |
Model 2b | 1 | 0.921 | 1.193 | 0.477 |
(Reference) | (0.659,1.286) | (0.830,1.714) | Â | |
Hypertriglyceridemia (%) | 56 | 28.4 | 15.6 | Â |
Unadjusted | 1 | 0.966 | 0.659 | 0.029 |
(Reference) | (0.725,1.287) | (0.469,0.925) | Â | |
Model 1a | 1 | 0.809 | 0.842 | 0.246 |
(Reference) | (0.584, 1.120) | (0.573,1.237) | Â | |
Model 2b | 1 | 0.793 | 0.843 | 0.239 |
(Reference) | (0.570,1.104) | (0.572,1.241) | Â | |
Hypoalphalipoproteinemia/HDL (%) | 54.2 | 37.6 | 8.1 | Â |
Unadjusted | 1 | 1.543 | 0.335 | 0.002 |
(Reference) | (1.146,2.078) | (0.211,0.533) | Â | |
Model 1a | 1 | 1.527 | 0.317 | 0.001 |
(Reference) | (1.131,2.061) | (0.199,0.506) | Â | |
Model 2b | 1 | 1.483 | 0.31 | 0.001 |
(Reference) | (1.092,2.013) | (0.192,0.499) | Â | |
Hypobetalipoproteinemia/LDL (%) | 47.2 | 27.8 | 25 | Â |
Unadjusted | 1 | 1.142 | 1.474 | 0.368 |
(Reference) | (0.516,20,525) | (0.647,3.361) | Â | |
Model 1a | 1 | 1.186 | 1.55 | 0.308 |
(Reference) | (0.534,2.632) | (0.675,3.556) | Â | |
Model 2b | 1 | 1.086 | 1.54 | 0.348 |
(Reference) | (0.482,2.446) | (0.663,3.576) | Â |